Skip to main content
Top
Published in: Journal of Translational Medicine 1/2022

Open Access 01-12-2022 | Ionizing Radiation | Research

Exploring the translational challenge for medical applications of ionising radiation and corresponding radiation protection research

Authors: Sophie Bockhold, Shane J. Foley, Louise A. Rainford, Riccardo Corridori, Annika Eberstein, Christoph Hoeschen, Mark W. Konijnenberg, Susan Molyneux-Hodgson, Graciano Paulo, Joana Santos, Jonathan P. McNulty

Published in: Journal of Translational Medicine | Issue 1/2022

Login to get access

Abstract

Background

Medical applications of ionising radiation and associated radiation protection research often encounter long delays and inconsistent implementation when translated into clinical practice. A coordinated effort is needed to analyse the research needs for innovation transfer in radiation-based high-quality healthcare across Europe which can inform the development of an innovation transfer framework tailored for equitable implementation of radiation research at scale.

Methods

Between March and September 2021 a Delphi methodology was employed to gain consensus on key translational challenges from a range of professional stakeholders. A total of three Delphi rounds were conducted using a series of electronic surveys comprised of open-ended and closed-type questions. The surveys were disseminated via the EURAMED Rocc-n-Roll consortium network and prominent medical societies in the field. Approximately 350 professionals were invited to participate. Participants’ level of agreement with each generated statement was captured using a 6-point Likert scale. Consensus was defined as median ≥ 4 with ≥ 60% of responses in the upper tertile of the scale. Additionally, the stability of responses across rounds was assessed.

Results

In the first Delphi round a multidisciplinary panel of 20 generated 127 unique statements. The second and third Delphi rounds recruited a broader sample of 130 individuals to rate the extent to which they agreed with each statement as a key translational challenge. A total of 60 consensus statements resulted from the iterative Delphi process of which 55 demonstrated good stability. Ten statements were identified as high priority challenges with ≥ 80% of statement ratings either ‘Agree’ or ‘Strongly Agree’.

Conclusion

A lack of interoperability between systems, insufficient resources, unsatisfactory education and training, and the need for greater public awareness surrounding the benefits, risks, and applications of ionising radiation were identified as principal translational challenges. These findings will help to inform a tailored innovation transfer framework for medical radiation research.
Appendix
Available only for authorised users
Literature
1.
go back to reference Waldman SA, Terzic A. Clinical and translational science: from bench-bedside to global village. Clin Transl Sci. 2010;3:254–7.CrossRef Waldman SA, Terzic A. Clinical and translational science: from bench-bedside to global village. Clin Transl Sci. 2010;3:254–7.CrossRef
2.
go back to reference Sardanelli F. Trends in radiology and experimental research. Eur Radiol Exp. 2017;1:1.CrossRef Sardanelli F. Trends in radiology and experimental research. Eur Radiol Exp. 2017;1:1.CrossRef
3.
go back to reference O’Connor JPB, Aboagye EO, Adams JE, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14:169–86.CrossRef O’Connor JPB, Aboagye EO, Adams JE, et al. Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol. 2017;14:169–86.CrossRef
4.
go back to reference Zambaiti E, Siles Hinojosa A, Montano V, et al. Interventional radiology-guided procedures in the treatment of pediatric solid tumors: a systematic review and meta-analysis. Eur J Pediatr Surg. 2020;30:317–25.CrossRef Zambaiti E, Siles Hinojosa A, Montano V, et al. Interventional radiology-guided procedures in the treatment of pediatric solid tumors: a systematic review and meta-analysis. Eur J Pediatr Surg. 2020;30:317–25.CrossRef
5.
go back to reference Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385(12):1091–103.CrossRef Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385(12):1091–103.CrossRef
6.
go back to reference Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. Phase 3 trial of (177)Lu-dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125–35.CrossRef Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. Phase 3 trial of (177)Lu-dotatate for midgut neuroendocrine tumors. N Engl J Med. 2017;376(2):125–35.CrossRef
7.
go back to reference Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–23.CrossRef Parker C, Nilsson S, Heinrich D, Helle SI, O’Sullivan JM, Fosså SD, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–23.CrossRef
8.
go back to reference Ballinger JR. Theranostic radiopharmaceuticals: established agents in current use. The Br J Radiol. 2018;91:20170969.CrossRef Ballinger JR. Theranostic radiopharmaceuticals: established agents in current use. The Br J Radiol. 2018;91:20170969.CrossRef
9.
go back to reference Kolenc Peitl P, Rangger C, Garnuszek P, Mikolajczak R, Hubalewska-Dydejczyk A, Maina T, et al. Clinical translation of theranostic radiopharmaceuticals: current regulatory status and recent examples. J Labelled Comp Radiopharm. 2019;62(10):673–83.CrossRef Kolenc Peitl P, Rangger C, Garnuszek P, Mikolajczak R, Hubalewska-Dydejczyk A, Maina T, et al. Clinical translation of theranostic radiopharmaceuticals: current regulatory status and recent examples. J Labelled Comp Radiopharm. 2019;62(10):673–83.CrossRef
10.
go back to reference Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomed. 2019;14:1937–52.CrossRef Mukherjee A, Waters AK, Kalyan P, Achrol AS, Kesari S, Yenugonda VM. Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomed. 2019;14:1937–52.CrossRef
11.
go back to reference Zhu L, Staley C, Kooby D, El-Rays B, Mao H, Yang L. Current status of biomarker and targeted nanoparticle development: the precision oncology approach for pancreatic cancer therapy. Cancer Lett. 2016;388:139–48.CrossRef Zhu L, Staley C, Kooby D, El-Rays B, Mao H, Yang L. Current status of biomarker and targeted nanoparticle development: the precision oncology approach for pancreatic cancer therapy. Cancer Lett. 2016;388:139–48.CrossRef
12.
go back to reference Shukla S, Steinmetz NF. Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine. Wires Nanomed Nanobi. 2015;7:708–21.CrossRef Shukla S, Steinmetz NF. Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine. Wires Nanomed Nanobi. 2015;7:708–21.CrossRef
13.
go back to reference Schaub L, Harrabi SB, Debus J. Particle therapy in the future of precision therapy. Br J Radiol. 2020;93(1114):20200183.CrossRef Schaub L, Harrabi SB, Debus J. Particle therapy in the future of precision therapy. Br J Radiol. 2020;93(1114):20200183.CrossRef
14.
go back to reference Malouff TD, Mahajan A, Krishnan S, Beltran C, Seneviratne DS, Trifiletti DM. Carbon ion therapy: a modern review of an emerging technology. Front Oncol. 2020;10:82.CrossRef Malouff TD, Mahajan A, Krishnan S, Beltran C, Seneviratne DS, Trifiletti DM. Carbon ion therapy: a modern review of an emerging technology. Front Oncol. 2020;10:82.CrossRef
15.
go back to reference Panayides AS, Amini A, Filipovic ND, et al. AI in medical imaging informatics: current challenges and future directions. IEEE J Biomed Health Inform. 2020;24:1837–57.CrossRef Panayides AS, Amini A, Filipovic ND, et al. AI in medical imaging informatics: current challenges and future directions. IEEE J Biomed Health Inform. 2020;24:1837–57.CrossRef
16.
go back to reference Visvikis D. Radiomics and Artificial Intelligence: what may the future bring [online presentation]. In: The 2021 European Congress of Radiology, (ed) In: Industry Symposium by SOPHiA GENETICS: Combining Genomics and Radiomics Data in Oncology: examples for lung and breast tumors, The 2021 European Congress of Radiology. 3–7 March, 2021. Visvikis D. Radiomics and Artificial Intelligence: what may the future bring [online presentation]. In: The 2021 European Congress of Radiology, (ed) In: Industry Symposium by SOPHiA GENETICS: Combining Genomics and Radiomics Data in Oncology: examples for lung and breast tumors, The 2021 European Congress of Radiology. 3–7 March, 2021.
17.
go back to reference Naqa IE, Haider MA, Giger ML, Haken RKT. Artificial Intelligence: reshaping the practice of radiological sciences in the 21st century. Br J Radiol. 2020;93:20190855.CrossRef Naqa IE, Haider MA, Giger ML, Haken RKT. Artificial Intelligence: reshaping the practice of radiological sciences in the 21st century. Br J Radiol. 2020;93:20190855.CrossRef
18.
go back to reference ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann. ICRP 37 (2–4) ICRP. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Ann. ICRP 37 (2–4)
24.
go back to reference Jacobs M, Boersma L, Merode FV, et al. How efficient is translational research in radiation oncology? The example of a large Dutch academic radiation oncology department. Br J Radiol. 2016;89:20160129.CrossRef Jacobs M, Boersma L, Merode FV, et al. How efficient is translational research in radiation oncology? The example of a large Dutch academic radiation oncology department. Br J Radiol. 2016;89:20160129.CrossRef
25.
go back to reference Butler D. Translational research: crossing the valley of death. Nature (London). 2008;453:840–2.CrossRef Butler D. Translational research: crossing the valley of death. Nature (London). 2008;453:840–2.CrossRef
27.
go back to reference Hanna CR, Lynskey DM, Wadsley J et al. Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions. Clinical Oncology 32: 266–275. Hanna CR, Lynskey DM, Wadsley J et al. Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions. Clinical Oncology 32: 266–275.
29.
go back to reference Chiesa C, Sjogreen Gleisner K, Flux G, Gear J, Walrand S, Bacher K, et al. The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. Eur J Nucl Med Mol Imaging. 2017;44(11):1783–6.CrossRef Chiesa C, Sjogreen Gleisner K, Flux G, Gear J, Walrand S, Bacher K, et al. The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. Eur J Nucl Med Mol Imaging. 2017;44(11):1783–6.CrossRef
30.
go back to reference Wang S, Summers RM. Machine learning and radiology. Med Image Anal. 2012;16:933–51.CrossRef Wang S, Summers RM. Machine learning and radiology. Med Image Anal. 2012;16:933–51.CrossRef
31.
go back to reference European Association of Nuclear Medicine, EANM; European Federation of Organizations for Medical Physics, EFOMP; European Federation of Radiographer Societies, EFRS; European Society of Radiology, ESR; European Society for Radiotherapy and Oncology, ESTRO. Common strategic research agenda for radiation protection in medicine. Insights into Imaging. 2017; 8:183–197. European Association of Nuclear Medicine, EANM; European Federation of Organizations for Medical Physics, EFOMP; European Federation of Radiographer Societies, EFRS; European Society of Radiology, ESR; European Society for Radiotherapy and Oncology, ESTRO. Common strategic research agenda for radiation protection in medicine. Insights into Imaging. 2017; 8:183–197.
32.
go back to reference Miyahira AK, Pienta KJ, Babich JW, Bander NH, Calais J, Choyke P, et al. Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting. Prostate. 2020;80(15):1273–96.CrossRef Miyahira AK, Pienta KJ, Babich JW, Bander NH, Calais J, Choyke P, et al. Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting. Prostate. 2020;80(15):1273–96.CrossRef
33.
go back to reference Bird D, Henry AM, Sebag-Montefiore D, Buckley DL, Al-Qaisieh B, Speight R. A systematic review of the clinical implementation of pelvic magnetic resonance imaging – only planning for external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2019;105:479–92.CrossRef Bird D, Henry AM, Sebag-Montefiore D, Buckley DL, Al-Qaisieh B, Speight R. A systematic review of the clinical implementation of pelvic magnetic resonance imaging – only planning for external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2019;105:479–92.CrossRef
34.
go back to reference Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401–9.CrossRef Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401–9.CrossRef
35.
go back to reference Jünger S, Payne SA, Brine J, Radbruch L, Brearley SG. Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review. Palliat Med. 2017;31(8):684–706.CrossRef Jünger S, Payne SA, Brine J, Radbruch L, Brearley SG. Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review. Palliat Med. 2017;31(8):684–706.CrossRef
36.
go back to reference Trevelyan EG, Robinson PN. Delphi methodology in health research: how to do it? Eur J Integr Med. 2015;7(4):423–8.CrossRef Trevelyan EG, Robinson PN. Delphi methodology in health research: how to do it? Eur J Integr Med. 2015;7(4):423–8.CrossRef
37.
go back to reference Levine AC, Barry MA, Agrawal P, Duber HC, Chang MP, Mackey JM, Hansoti B; Global Emergency Medicine Think Tank Clinical Research Working Group. Global Health and Emergency Care: Overcoming Clinical Research Barriers. Acad Emerg Med. 2017;24(4):484–493. doi: https://doi.org/10.1111/acem.13142. Levine AC, Barry MA, Agrawal P, Duber HC, Chang MP, Mackey JM, Hansoti B; Global Emergency Medicine Think Tank Clinical Research Working Group. Global Health and Emergency Care: Overcoming Clinical Research Barriers. Acad Emerg Med. 2017;24(4):484–493. doi: https://​doi.​org/​10.​1111/​acem.​13142.
41.
go back to reference Battaglia M, Furlong P, Wulffraat NM, Bellutti EF. Improving the translational medicine process: moving patients from “End-Users” to “Engaged Collaborators.” Front Med. 2019;6:110–110.CrossRef Battaglia M, Furlong P, Wulffraat NM, Bellutti EF. Improving the translational medicine process: moving patients from “End-Users” to “Engaged Collaborators.” Front Med. 2019;6:110–110.CrossRef
42.
go back to reference Cohrs RJ, Martin T, Ghahramani P, Bidaut L, Higgins PJ, Shahzad A. Translational medicine definition by the European society for translational medicine. New Horiz Transl Med. 2015;2(3):86–8. Cohrs RJ, Martin T, Ghahramani P, Bidaut L, Higgins PJ, Shahzad A. Translational medicine definition by the European society for translational medicine. New Horiz Transl Med. 2015;2(3):86–8.
43.
44.
45.
go back to reference Kalaitzopoulos D, Patel K, Younesi E. Chapter 2: Advancements in Data Management and Data Mining Approaches. In: Shahzad A, (ed) Translational Medicine: Tools and Techniques. Elsevier, Vienna, Austria. 2016. Kalaitzopoulos D, Patel K, Younesi E. Chapter 2: Advancements in Data Management and Data Mining Approaches. In: Shahzad A, (ed) Translational Medicine: Tools and Techniques. Elsevier, Vienna, Austria. 2016.
47.
go back to reference Fahy N, Hervey T, Greer S, Jarman H, Stuckler D, Galsworthy M, et al. How will Brexit affect health services in the UK? An updated evaluation. Lancet. 2019;393(10174):949–58.CrossRef Fahy N, Hervey T, Greer S, Jarman H, Stuckler D, Galsworthy M, et al. How will Brexit affect health services in the UK? An updated evaluation. Lancet. 2019;393(10174):949–58.CrossRef
48.
go back to reference Piorkowska M, Goh V, Booth TC. Post Brexit: challenges and opportunities for radiology beyond the European Union. Br J Radiol. 2017;90(1072):20160852.CrossRef Piorkowska M, Goh V, Booth TC. Post Brexit: challenges and opportunities for radiology beyond the European Union. Br J Radiol. 2017;90(1072):20160852.CrossRef
49.
go back to reference van Schalkwyk MCI, Hervey TK, McCarey M, Dayan M, Barlow P, McKee M. How will Brexit affect the healthcare workforce? BMJ. 2020;371:4439.CrossRef van Schalkwyk MCI, Hervey TK, McCarey M, Dayan M, Barlow P, McKee M. How will Brexit affect the healthcare workforce? BMJ. 2020;371:4439.CrossRef
50.
go back to reference Sjögreen Gleisner K, Spezi E, Solny P, Gabina PM, Cicone F, Stokke C, et al. Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey. EJNMMI Phys. 2017;4(1):28.CrossRef Sjögreen Gleisner K, Spezi E, Solny P, Gabina PM, Cicone F, Stokke C, et al. Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey. EJNMMI Phys. 2017;4(1):28.CrossRef
Metadata
Title
Exploring the translational challenge for medical applications of ionising radiation and corresponding radiation protection research
Authors
Sophie Bockhold
Shane J. Foley
Louise A. Rainford
Riccardo Corridori
Annika Eberstein
Christoph Hoeschen
Mark W. Konijnenberg
Susan Molyneux-Hodgson
Graciano Paulo
Joana Santos
Jonathan P. McNulty
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2022
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-022-03344-4

Other articles of this Issue 1/2022

Journal of Translational Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.